Clinicopathological Manifestations and Immune Phenotypes in Adult-Onset Immunodeficiency with Anti-interferon-γ Autoantibodies

Purpose Anti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct disorder remains to be clarified. Methods We prospectively collected blood samples of 20 patients with anti-IFN-γ Abs and 40 healthy normal subjec...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical immunology Vol. 42; no. 3; pp. 672 - 683
Main Authors Chen, Yi-Chun, Weng, Shao-Wen, Ding, Jing-Ya, Lee, Chen-Hsiang, Ku, Cheng-Lung, Huang, Wen-Chi, You, Huey-Ling, Huang, Wan-Ting
Format Journal Article
LanguageEnglish
Published New York Springer US 01.04.2022
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0271-9142
1573-2592
1573-2592
DOI10.1007/s10875-022-01210-y

Cover

Abstract Purpose Anti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct disorder remains to be clarified. Methods We prospectively collected blood samples of 20 patients with anti-IFN-γ Abs and 40 healthy normal subjects. The percentages of lymphocyte subpopulations, most relevant to T, B, and NK cells, and the percentages of stimulated lymphocytes with cytokine production were assessed using eight-color flow cytometry. The results were adjusted to age and absolute lymphocyte counts. Results Most (85%) patients presented nontuberculous mycobacterial infection. Skin lesions were predominantly manifested by neutrophilic dermatoses. The involved lymph nodes had granulomatous inflammation, except 22.2% showing atypical lymphoid hyperplasia without granuloma formation. The percentages of CD4 + T cells and nonactivated subpopulations (recent thymic emigrants and naïve subtypes) decreased significantly with increased expression of activation markers and polarization to differentiated cells. The percentage of NK cells increased, but that of two major NK subpopulations, CD161 + CD56 bright and CD161 + CD56 + CD16 + subsets, decreased. Increased CD161 dim , CD161 + CD56 − CD16 + , and CD57 + NK cell subsets coupled with the decreased expression of NKp30 and NKp46 indicate reconfiguration of the NK cell population and acquisition of adaptive features. Intracellular cytokine production of the lymphocyte subpopulations was significantly low in the patients compared with the control group. Conclusion We conclude that the immune system in patients with anti-IFN-γ Abs could be exhausted in T cells and be adaptive in NK cells, contributing to the distinct clinicopathologic features.
AbstractList PurposeAnti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct disorder remains to be clarified.MethodsWe prospectively collected blood samples of 20 patients with anti-IFN-γ Abs and 40 healthy normal subjects. The percentages of lymphocyte subpopulations, most relevant to T, B, and NK cells, and the percentages of stimulated lymphocytes with cytokine production were assessed using eight-color flow cytometry. The results were adjusted to age and absolute lymphocyte counts.ResultsMost (85%) patients presented nontuberculous mycobacterial infection. Skin lesions were predominantly manifested by neutrophilic dermatoses. The involved lymph nodes had granulomatous inflammation, except 22.2% showing atypical lymphoid hyperplasia without granuloma formation. The percentages of CD4 + T cells and nonactivated subpopulations (recent thymic emigrants and naïve subtypes) decreased significantly with increased expression of activation markers and polarization to differentiated cells. The percentage of NK cells increased, but that of two major NK subpopulations, CD161 + CD56bright and CD161 + CD56 + CD16 + subsets, decreased. Increased CD161dim, CD161 + CD56 − CD16 + , and CD57 + NK cell subsets coupled with the decreased expression of NKp30 and NKp46 indicate reconfiguration of the NK cell population and acquisition of adaptive features. Intracellular cytokine production of the lymphocyte subpopulations was significantly low in the patients compared with the control group.ConclusionWe conclude that the immune system in patients with anti-IFN-γ Abs could be exhausted in T cells and be adaptive in NK cells, contributing to the distinct clinicopathologic features.
Anti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct disorder remains to be clarified.PURPOSEAnti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct disorder remains to be clarified.We prospectively collected blood samples of 20 patients with anti-IFN-γ Abs and 40 healthy normal subjects. The percentages of lymphocyte subpopulations, most relevant to T, B, and NK cells, and the percentages of stimulated lymphocytes with cytokine production were assessed using eight-color flow cytometry. The results were adjusted to age and absolute lymphocyte counts.METHODSWe prospectively collected blood samples of 20 patients with anti-IFN-γ Abs and 40 healthy normal subjects. The percentages of lymphocyte subpopulations, most relevant to T, B, and NK cells, and the percentages of stimulated lymphocytes with cytokine production were assessed using eight-color flow cytometry. The results were adjusted to age and absolute lymphocyte counts.Most (85%) patients presented nontuberculous mycobacterial infection. Skin lesions were predominantly manifested by neutrophilic dermatoses. The involved lymph nodes had granulomatous inflammation, except 22.2% showing atypical lymphoid hyperplasia without granuloma formation. The percentages of CD4 + T cells and nonactivated subpopulations (recent thymic emigrants and naïve subtypes) decreased significantly with increased expression of activation markers and polarization to differentiated cells. The percentage of NK cells increased, but that of two major NK subpopulations, CD161 + CD56bright and CD161 + CD56 + CD16 + subsets, decreased. Increased CD161dim, CD161 + CD56 - CD16 + , and CD57 + NK cell subsets coupled with the decreased expression of NKp30 and NKp46 indicate reconfiguration of the NK cell population and acquisition of adaptive features. Intracellular cytokine production of the lymphocyte subpopulations was significantly low in the patients compared with the control group.RESULTSMost (85%) patients presented nontuberculous mycobacterial infection. Skin lesions were predominantly manifested by neutrophilic dermatoses. The involved lymph nodes had granulomatous inflammation, except 22.2% showing atypical lymphoid hyperplasia without granuloma formation. The percentages of CD4 + T cells and nonactivated subpopulations (recent thymic emigrants and naïve subtypes) decreased significantly with increased expression of activation markers and polarization to differentiated cells. The percentage of NK cells increased, but that of two major NK subpopulations, CD161 + CD56bright and CD161 + CD56 + CD16 + subsets, decreased. Increased CD161dim, CD161 + CD56 - CD16 + , and CD57 + NK cell subsets coupled with the decreased expression of NKp30 and NKp46 indicate reconfiguration of the NK cell population and acquisition of adaptive features. Intracellular cytokine production of the lymphocyte subpopulations was significantly low in the patients compared with the control group.We conclude that the immune system in patients with anti-IFN-γ Abs could be exhausted in T cells and be adaptive in NK cells, contributing to the distinct clinicopathologic features.CONCLUSIONWe conclude that the immune system in patients with anti-IFN-γ Abs could be exhausted in T cells and be adaptive in NK cells, contributing to the distinct clinicopathologic features.
Purpose Anti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct disorder remains to be clarified. Methods We prospectively collected blood samples of 20 patients with anti-IFN-γ Abs and 40 healthy normal subjects. The percentages of lymphocyte subpopulations, most relevant to T, B, and NK cells, and the percentages of stimulated lymphocytes with cytokine production were assessed using eight-color flow cytometry. The results were adjusted to age and absolute lymphocyte counts. Results Most (85%) patients presented nontuberculous mycobacterial infection. Skin lesions were predominantly manifested by neutrophilic dermatoses. The involved lymph nodes had granulomatous inflammation, except 22.2% showing atypical lymphoid hyperplasia without granuloma formation. The percentages of CD4 + T cells and nonactivated subpopulations (recent thymic emigrants and naïve subtypes) decreased significantly with increased expression of activation markers and polarization to differentiated cells. The percentage of NK cells increased, but that of two major NK subpopulations, CD161 + CD56 bright and CD161 + CD56 + CD16 + subsets, decreased. Increased CD161 dim , CD161 + CD56 − CD16 + , and CD57 + NK cell subsets coupled with the decreased expression of NKp30 and NKp46 indicate reconfiguration of the NK cell population and acquisition of adaptive features. Intracellular cytokine production of the lymphocyte subpopulations was significantly low in the patients compared with the control group. Conclusion We conclude that the immune system in patients with anti-IFN-γ Abs could be exhausted in T cells and be adaptive in NK cells, contributing to the distinct clinicopathologic features.
Anti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct disorder remains to be clarified. We prospectively collected blood samples of 20 patients with anti-IFN-γ Abs and 40 healthy normal subjects. The percentages of lymphocyte subpopulations, most relevant to T, B, and NK cells, and the percentages of stimulated lymphocytes with cytokine production were assessed using eight-color flow cytometry. The results were adjusted to age and absolute lymphocyte counts. Most (85%) patients presented nontuberculous mycobacterial infection. Skin lesions were predominantly manifested by neutrophilic dermatoses. The involved lymph nodes had granulomatous inflammation, except 22.2% showing atypical lymphoid hyperplasia without granuloma formation. The percentages of CD4 + T cells and nonactivated subpopulations (recent thymic emigrants and naïve subtypes) decreased significantly with increased expression of activation markers and polarization to differentiated cells. The percentage of NK cells increased, but that of two major NK subpopulations, CD161 + CD56 and CD161 + CD56 + CD16 + subsets, decreased. Increased CD161 , CD161 + CD56 - CD16 + , and CD57 + NK cell subsets coupled with the decreased expression of NKp30 and NKp46 indicate reconfiguration of the NK cell population and acquisition of adaptive features. Intracellular cytokine production of the lymphocyte subpopulations was significantly low in the patients compared with the control group. We conclude that the immune system in patients with anti-IFN-γ Abs could be exhausted in T cells and be adaptive in NK cells, contributing to the distinct clinicopathologic features.
Author Chen, Yi-Chun
You, Huey-Ling
Huang, Wan-Ting
Huang, Wen-Chi
Ku, Cheng-Lung
Ding, Jing-Ya
Weng, Shao-Wen
Lee, Chen-Hsiang
Author_xml – sequence: 1
  givenname: Yi-Chun
  surname: Chen
  fullname: Chen, Yi-Chun
  organization: Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital
– sequence: 2
  givenname: Shao-Wen
  surname: Weng
  fullname: Weng, Shao-Wen
  organization: Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, School of Medicine, College of Medicine, Chang Gung University
– sequence: 3
  givenname: Jing-Ya
  surname: Ding
  fullname: Ding, Jing-Ya
  organization: Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University
– sequence: 4
  givenname: Chen-Hsiang
  surname: Lee
  fullname: Lee, Chen-Hsiang
  organization: Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, School of Medicine, College of Medicine, Chang Gung University
– sequence: 5
  givenname: Cheng-Lung
  surname: Ku
  fullname: Ku, Cheng-Lung
  organization: Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Department of Nephrology, Linkou Chang Gung Memorial Hospital, Center for Molecular and Clinical Immunology, Chang Gung University
– sequence: 6
  givenname: Wen-Chi
  surname: Huang
  fullname: Huang, Wen-Chi
  organization: Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital
– sequence: 7
  givenname: Huey-Ling
  surname: You
  fullname: You, Huey-Ling
  organization: Department of Laboratory Medicine, Kaohsiung Chang Gung Memorial Hospital, Department of Medical Laboratory Sciences and Biotechnology, Fooyin University
– sequence: 8
  givenname: Wan-Ting
  orcidid: 0000-0001-6442-3713
  surname: Huang
  fullname: Huang, Wan-Ting
  email: huangwanting5@gmail.com
  organization: School of Medicine, College of Medicine, Chang Gung University, Department of Laboratory Medicine, Kaohsiung Chang Gung Memorial Hospital, Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Department of Pathology, Kaohsiung Chang Gung Memorial Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35089479$$D View this record in MEDLINE/PubMed
BookMark eNp9kctq3DAUhkVJaSZpX6CLYuimGzW6WJa9HIZeAgnpIlkLXY4zCrY0lWSCV32ovkefqU6dUMgiK8Hh-36Ozn-CjkIMgNB7Sj5TQuRZpqSVAhPGMKGMEjy_QhsqJMdMdOwIbQiTFHe0ZsfoJOc7QghvmHiDjrkgbVfLboN-7QYfvI0HXfZxiLfe6qG61MH3kIsuPoZc6eCq83GcAlQ_9hBimQ-QKx-qrZuGgq9ChrIC0UHvrYdg5-rel321DcVjHwqkHlIM-M_vajuVqJexic5Dfote93rI8O7xPUU3X79c777ji6tv57vtBbZcioLrXpiWSioM5dTQWgpnnRa9FYKxvrZdU3e8dcbZxlpaA3DjDNQSjBHaNJyfok9r7iHFn9PyNzX6bGEYdIA4ZcUaxtuO0K5e0I_P0Ls4pbBst1CCdkQy8RD44ZGazAhOHZIfdZrV02kXoF0Bm2LOCXpl_XrRkrQfFCXqoUW1tqiWFtW_FtW8qOyZ-pT-osRXKS9wuIX0f-0XrL9W2LMY
CitedBy_id crossref_primary_10_1186_s12879_023_08404_8
crossref_primary_10_3390_pathogens13010012
crossref_primary_10_1590_fst_003523
crossref_primary_10_3390_vaccines10091550
crossref_primary_10_1007_s10875_022_01423_1
crossref_primary_10_1007_s10875_023_01643_z
crossref_primary_10_1038_s41577_023_00933_2
crossref_primary_10_1042_BST20221374
crossref_primary_10_1159_000526284
crossref_primary_10_3389_fimmu_2024_1355681
crossref_primary_10_1002_rcr2_1178
crossref_primary_10_1080_22221751_2024_2396887
Cites_doi 10.1073/pnas.0409872102
10.1016/S1473-3099(15)00089-4
10.1007/s00439-020-02180-0
10.1155/2010/347142
10.1111/apm.12492
10.1093/cid/ciz786
10.1182/blood-2012-08-452482
10.1111/j.1365-3083.2005.01692.x
10.1182/blood-2010-04-282301
10.2340/00015555-2959
10.1016/j.cmi.2020.02.030
10.1056/NEJMoa1111160
10.1007/s00262-016-1803-z
10.3389/fcimb.2020.00162
10.1016/j.coi.2021.05.007
10.1177/1535370220981579
10.1016/j.kjms.2017.03.005
10.4049/jimmunol.1502570
10.1038/s41467-018-03243-7
10.3389/fimmu.2017.00936
10.1038/s41598-019-41952-1
10.1146/annurev-immunol-020711-075005
10.1002/cytob.21162
10.3389/fimmu.2018.00486
10.3389/fimmu.2013.00422
10.1146/annurev-immunol-032712-100010
10.3389/fimmu.2021.706244
10.1371/journal.pone.0110276
10.1371/journal.pone.0163604
10.1371/journal.pone.0128481
10.1093/cid/ciaa1098
10.1371/journal.pone.0145983
10.1084/jem.20190502
10.1097/MD.0000000000003927
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
– notice: 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
– notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
DOI 10.1007/s10875-022-01210-y
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
ProQuest Biological Science
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-2592
EndPage 683
ExternalDocumentID 35089479
10_1007_s10875_022_01210_y
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Kaohsiung Chang Gung Memorial Hospital
  grantid: CMRPG8K0341
  funderid: http://dx.doi.org/10.13039/501100011892
– fundername: Kaohsiung Chang Gung Memorial Hospital
  grantid: CMRPG8K0341
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29K
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AAJSJ
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACULB
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
D-I
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAK
LK8
LLZTM
M1P
M4Y
M7P
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
RNS
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
VVN
W23
W48
WJK
WK6
WK8
Y6R
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABEEZ
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFGXO
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7XB
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
7X8
PUEGO
ID FETCH-LOGICAL-c375t-4f5b81715b131b1475dcda5fc5522f4c964938dbdc6cc14ee3bdbe47ebb5ab633
IEDL.DBID 8C1
ISSN 0271-9142
1573-2592
IngestDate Sat Sep 27 18:19:50 EDT 2025
Fri Jul 25 19:43:45 EDT 2025
Wed Feb 19 02:25:52 EST 2025
Tue Jul 01 03:13:25 EDT 2025
Thu Apr 24 23:07:34 EDT 2025
Fri Feb 21 02:46:31 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Anti-interferon-γ autoantibody
Lymphocyte subpopulations
Cytokine production
Adult-onset immunodeficiency
Language English
License 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-4f5b81715b131b1475dcda5fc5522f4c964938dbdc6cc14ee3bdbe47ebb5ab633
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6442-3713
PMID 35089479
PQID 2651907253
PQPubID 37573
PageCount 12
ParticipantIDs proquest_miscellaneous_2623890194
proquest_journals_2651907253
pubmed_primary_35089479
crossref_citationtrail_10_1007_s10875_022_01210_y
crossref_primary_10_1007_s10875_022_01210_y
springer_journals_10_1007_s10875_022_01210_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20220400
2022-04-00
20220401
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 4
  year: 2022
  text: 20220400
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Netherlands
PublicationSubtitle International Journal of Inborn Errors of Immunity and Related Diseases
PublicationTitle Journal of clinical immunology
PublicationTitleAbbrev J Clin Immunol
PublicationTitleAlternate J Clin Immunol
PublicationYear 2022
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Long, Kim, Liu, Peterson, Rajagopalan (CR23) 2013; 31
Shih, Ding, Yeh, Chi, Ku (CR30) 2021; 72
Gonzalez, Taborda, Rugeles (CR11) 2017; 8
Lim, Allison, Tan, Oliver, Price, Waterer (CR20) 2010; 29
Wang, Zhu, Nguyen, Wan, Sant, Quiñones-Parra (CR31) 2018; 9
Lopez-Vergès, Milush, Pandey, York, Arakawa-Hoyt, Pircher (CR24) 2010; 116
Kared, Martelli, Ng, Pender, Larbi (CR15) 2016; 65
Boldt, Borte, Fricke, Kentouche, Emmrich, Borte (CR2) 2014; 86
CR16
Michel, Poli, Cuapio, Briquemont, Iserentant, Ollert (CR26) 2016; 196
Fink (CR9) 2013; 31
CR12
Li, Huang, Ku, Lee (CR21) 2017; 33
CR32
Batoni, Esin, Favilli, Pardini, Bottai, Maisetta (CR1) 2005; 62
Ku, Chi, von Bernuth, Doffinger (CR18) 2020; 139
Forconi, Oduor, Oluoch, Ong'echa, Munz, Bailey (CR10) 2020; 10
Mavilio, Lombardo, Benjamin, Kim, Follman, Marcenaro (CR25) 2005; 102
Wu, Holland (CR33) 2015; 15
Kurioka, Cosgrove, Simoni, van Wilgenburg, Geremia, Bjorkander (CR19) 2018; 9
CR6
Krisnawati, Liu, Lee, Wang, Chen, Tseng (CR17) 2019; 9
CR8
Liu, Weng, Wang, Huang (CR22) 2016; 124
Browne, Burbelo, Chetchotisakd, Suputtamongkol, Kiertiburanakul, Shaw (CR3) 2012; 367
CR7
Hong, Ortega-Villa, Hunsberger, Chetchotisakd, Anunnatsiri, Mootsikapun (CR13) 2020; 71
CR29
Nielsen, White, Goodier, Riley (CR28) 2013; 4
CR27
Jutivorakool, Sittiwattanawong, Kantikosum, Hurst, Kumtornrut, Asawanonda (CR14) 2018; 98
Chi, Chu, Liu, Lin, Ho, Lo, Lin, Chen, Chou, Feng (CR5) 2013; 121
Chawansuntati, Rattanathammethee, Wipasa (CR4) 2021; 246
Wu, Wang, Sheng, Sun, Cheng, Hsu (CR34) 2020; 26
GH Hong (1210_CR13) 2020; 71
CS Forconi (1210_CR10) 2020; 10
1210_CR32
A Kurioka (1210_CR19) 2018; 9
HP Shih (1210_CR30) 2021; 72
UI Wu (1210_CR33) 2015; 15
1210_CR12
T Michel (1210_CR26) 2016; 196
CY Chi (1210_CR5) 2013; 121
G Batoni (1210_CR1) 2005; 62
PJ Fink (1210_CR9) 2013; 31
1210_CR8
1210_CR7
1210_CR6
TT Liu (1210_CR22) 2016; 124
1210_CR16
K Chawansuntati (1210_CR4) 2021; 246
K Jutivorakool (1210_CR14) 2018; 98
A Boldt (1210_CR2) 2014; 86
WS Li (1210_CR21) 2017; 33
D Mavilio (1210_CR25) 2005; 102
SK Browne (1210_CR3) 2012; 367
Z Wang (1210_CR31) 2018; 9
H Kared (1210_CR15) 2016; 65
DI Krisnawati (1210_CR17) 2019; 9
UI Wu (1210_CR34) 2020; 26
CL Ku (1210_CR18) 2020; 139
S Lopez-Vergès (1210_CR24) 2010; 116
EO Long (1210_CR23) 2013; 31
SM Gonzalez (1210_CR11) 2017; 8
1210_CR27
A Lim (1210_CR20) 2010; 29
1210_CR29
CM Nielsen (1210_CR28) 2013; 4
References_xml – volume: 102
  start-page: 2886
  issue: 8
  year: 2005
  end-page: 2891
  ident: CR25
  article-title: Characterization of CD56−/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0409872102
– volume: 15
  start-page: 968
  issue: 8
  year: 2015
  end-page: 980
  ident: CR33
  article-title: Host susceptibility to non-tuberculous mycobacterial infections
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(15)00089-4
– volume: 139
  start-page: 783
  issue: 6–7
  year: 2020
  end-page: 794
  ident: CR18
  article-title: Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?
  publication-title: Hum Genet
  doi: 10.1007/s00439-020-02180-0
– volume: 29
  start-page: 103
  issue: 2
  year: 2010
  end-page: 109
  ident: CR20
  article-title: Immunological markers of lung disease due to non-tuberculous mycobacteria
  publication-title: Dis Markers
  doi: 10.1155/2010/347142
– ident: CR16
– volume: 124
  start-page: 216
  issue: 3
  year: 2016
  end-page: 220
  ident: CR22
  article-title: Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy
  publication-title: APMIS
  doi: 10.1111/apm.12492
– ident: CR12
– volume: 71
  start-page: 53
  issue: 1
  year: 2020
  end-page: 62
  ident: CR13
  article-title: Natural history and evolution of anti-interferon-gamma autoantibody-associated immunodeficiency syndrome in Thailand and the United States
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciz786
– volume: 121
  start-page: 1357
  issue: 8
  year: 2013
  end-page: 1366
  ident: CR5
  article-title: Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection
  publication-title: Blood
  doi: 10.1182/blood-2012-08-452482
– volume: 62
  start-page: 498
  issue: 6
  year: 2005
  end-page: 506
  ident: CR1
  article-title: Human CD56 and CD56 natural killer cell subsets respond differentially to direct stimulation with bacillus Calmette-Guerin
  publication-title: Scand J Immunol
  doi: 10.1111/j.1365-3083.2005.01692.x
– volume: 116
  start-page: 3865
  issue: 19
  year: 2010
  end-page: 3874
  ident: CR24
  article-title: CD57 defines a functionally distinct population of mature NK cells in the human CD56 CD16+ NK-cell subset
  publication-title: Blood
  doi: 10.1182/blood-2010-04-282301
– ident: CR6
– volume: 98
  start-page: 742
  issue: 8
  year: 2018
  end-page: 747
  ident: CR14
  article-title: Skin manifestations in patients with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: a relationship with systemic infections
  publication-title: Acta Derm Venereol
  doi: 10.2340/00015555-2959
– ident: CR29
– volume: 26
  start-page: 1684.e1
  issue: 12
  year: 2020
  end-page: 6
  ident: CR34
  article-title: Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2020.02.030
– volume: 367
  start-page: 725
  issue: 8
  year: 2012
  end-page: 734
  ident: CR3
  article-title: Adult-onset immunodeficiency in Thailand and Taiwan
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1111160
– ident: CR8
– volume: 65
  start-page: 441
  issue: 4
  year: 2016
  end-page: 452
  ident: CR15
  article-title: CD57 in human natural killer cells and T-lymphocytes
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-016-1803-z
– volume: 10
  start-page: 162
  year: 2020
  ident: CR10
  article-title: A new hope for CD56(neg)CD16(pos) NK cells as unconventional cytotoxic mediators: an adaptation to chronic diseases
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2020.00162
– ident: CR27
– volume: 72
  start-page: 206
  year: 2021
  end-page: 214
  ident: CR30
  article-title: Anti-interferon-gamma autoantibody-associated immunodeficiency
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2021.05.007
– volume: 246
  start-page: 790
  issue: 7
  year: 2021
  end-page: 795
  ident: CR4
  article-title: Minireview: Insights into anti-interferon-gamma autoantibodies
  publication-title: Exp Biol Med (Maywood)
  doi: 10.1177/1535370220981579
– volume: 33
  start-page: 365
  issue: 7
  year: 2017
  end-page: 366
  ident: CR21
  article-title: Osteolytic lesions resulting from opportunistic infections
  publication-title: Kaohsiung J Med Sci
  doi: 10.1016/j.kjms.2017.03.005
– volume: 196
  start-page: 2923
  issue: 7
  year: 2016
  end-page: 2931
  ident: CR26
  article-title: Human CD56 NK cells: an update
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1502570
– volume: 9
  start-page: 824
  issue: 1
  year: 2018
  ident: CR31
  article-title: Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-03243-7
– volume: 8
  start-page: 936
  year: 2017
  ident: CR11
  article-title: Role of different subpopulations of CD8+ T cells during HIV exposure and infection
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00936
– volume: 9
  start-page: 5682
  issue: 1
  year: 2019
  ident: CR17
  article-title: Functional neutralization of anti-IFN-gamma autoantibody in patients with nontuberculous mycobacteria infection
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-41952-1
– volume: 31
  start-page: 227
  year: 2013
  end-page: 258
  ident: CR23
  article-title: Controlling natural killer cell responses: integration of signals for activation and inhibition
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-020711-075005
– ident: CR32
– ident: CR7
– volume: 86
  start-page: 191
  issue: 3
  year: 2014
  end-page: 206
  ident: CR2
  article-title: Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies
  publication-title: Cytometry B Clin Cytom
  doi: 10.1002/cytob.21162
– volume: 9
  start-page: 486
  year: 2018
  ident: CR19
  article-title: CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.00486
– volume: 4
  start-page: 422
  year: 2013
  ident: CR28
  article-title: Functional significance of CD57 expression on human NK cells and relevance to disease
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2013.00422
– volume: 31
  start-page: 31
  year: 2013
  end-page: 50
  ident: CR9
  article-title: The biology of recent thymic emigrants
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-032712-100010
– volume: 9
  start-page: 486
  year: 2018
  ident: 1210_CR19
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.00486
– ident: 1210_CR8
  doi: 10.3389/fimmu.2021.706244
– volume: 65
  start-page: 441
  issue: 4
  year: 2016
  ident: 1210_CR15
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-016-1803-z
– volume: 72
  start-page: 206
  year: 2021
  ident: 1210_CR30
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2021.05.007
– ident: 1210_CR32
  doi: 10.1371/journal.pone.0110276
– ident: 1210_CR27
  doi: 10.1371/journal.pone.0163604
– volume: 124
  start-page: 216
  issue: 3
  year: 2016
  ident: 1210_CR22
  publication-title: APMIS
  doi: 10.1111/apm.12492
– ident: 1210_CR29
  doi: 10.1371/journal.pone.0128481
– ident: 1210_CR16
  doi: 10.1093/cid/ciaa1098
– volume: 9
  start-page: 5682
  issue: 1
  year: 2019
  ident: 1210_CR17
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-41952-1
– volume: 86
  start-page: 191
  issue: 3
  year: 2014
  ident: 1210_CR2
  publication-title: Cytometry B Clin Cytom
  doi: 10.1002/cytob.21162
– volume: 121
  start-page: 1357
  issue: 8
  year: 2013
  ident: 1210_CR5
  publication-title: Blood
  doi: 10.1182/blood-2012-08-452482
– ident: 1210_CR7
  doi: 10.1371/journal.pone.0145983
– volume: 29
  start-page: 103
  issue: 2
  year: 2010
  ident: 1210_CR20
  publication-title: Dis Markers
  doi: 10.1155/2010/347142
– volume: 367
  start-page: 725
  issue: 8
  year: 2012
  ident: 1210_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1111160
– volume: 246
  start-page: 790
  issue: 7
  year: 2021
  ident: 1210_CR4
  publication-title: Exp Biol Med (Maywood)
  doi: 10.1177/1535370220981579
– volume: 98
  start-page: 742
  issue: 8
  year: 2018
  ident: 1210_CR14
  publication-title: Acta Derm Venereol
  doi: 10.2340/00015555-2959
– volume: 33
  start-page: 365
  issue: 7
  year: 2017
  ident: 1210_CR21
  publication-title: Kaohsiung J Med Sci
  doi: 10.1016/j.kjms.2017.03.005
– ident: 1210_CR12
  doi: 10.1084/jem.20190502
– volume: 116
  start-page: 3865
  issue: 19
  year: 2010
  ident: 1210_CR24
  publication-title: Blood
  doi: 10.1182/blood-2010-04-282301
– volume: 31
  start-page: 31
  year: 2013
  ident: 1210_CR9
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-032712-100010
– volume: 15
  start-page: 968
  issue: 8
  year: 2015
  ident: 1210_CR33
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(15)00089-4
– volume: 102
  start-page: 2886
  issue: 8
  year: 2005
  ident: 1210_CR25
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0409872102
– volume: 31
  start-page: 227
  year: 2013
  ident: 1210_CR23
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-020711-075005
– volume: 62
  start-page: 498
  issue: 6
  year: 2005
  ident: 1210_CR1
  publication-title: Scand J Immunol
  doi: 10.1111/j.1365-3083.2005.01692.x
– ident: 1210_CR6
  doi: 10.1097/MD.0000000000003927
– volume: 196
  start-page: 2923
  issue: 7
  year: 2016
  ident: 1210_CR26
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1502570
– volume: 139
  start-page: 783
  issue: 6–7
  year: 2020
  ident: 1210_CR18
  publication-title: Hum Genet
  doi: 10.1007/s00439-020-02180-0
– volume: 71
  start-page: 53
  issue: 1
  year: 2020
  ident: 1210_CR13
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciz786
– volume: 10
  start-page: 162
  year: 2020
  ident: 1210_CR10
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2020.00162
– volume: 8
  start-page: 936
  year: 2017
  ident: 1210_CR11
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00936
– volume: 26
  start-page: 1684.e1
  issue: 12
  year: 2020
  ident: 1210_CR34
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2020.02.030
– volume: 4
  start-page: 422
  year: 2013
  ident: 1210_CR28
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2013.00422
– volume: 9
  start-page: 824
  issue: 1
  year: 2018
  ident: 1210_CR31
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-03243-7
SSID ssj0003625
Score 2.4235487
Snippet Purpose Anti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct...
Anti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct disorder...
PurposeAnti-interferon (IFN)-γ autoantibodies (anti-IFN-γ Abs) is an emerging adult-onset immunodeficiency syndrome. Immune dysfunction in this distinct...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 672
SubjectTerms Autoantibodies
Autoantibodies - metabolism
Biomedical and Life Sciences
Biomedicine
CD16 antigen
CD4 antigen
CD56 antigen
CD56 Antigen - metabolism
CD57 antigen
Cell differentiation
Cytokines
Flow Cytometry
Granuloma
Humans
Hyperplasia
Immune system
Immunodeficiency
Immunologic Deficiency Syndromes - diagnosis
Immunologic Deficiency Syndromes - metabolism
Immunology
Infectious Diseases
Interferon-gamma - metabolism
Internal Medicine
Killer Cells, Natural
Leukocytes (neutrophilic)
Lymph nodes
Lymphocytes
Lymphocytes T
Medical Microbiology
Natural killer cells
Original Article
Phenotype
Phenotypes
Skin diseases
Skin lesions
Thymus
γ-Interferon
SummonAdditionalLinks – databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkRCXivIMtMhI3MBSnPiRHFcrqoK0wIFKvUV-TMRKyEGb7KGn_ij-B78JT5LdCgpInDO2o3z2-Itn5jPAq7y2xgkvuUITuPS15y5XnitbaeuclW2gH8XVB312Lt9fqItZJodqYX6L31OJW2LUnHLOSX0s55e34Y5Kjpdm81Iv9143OeIxXbEwIi1gWcwFMn_u49dN6AazvBEVHTeb0_twOLNEtphgPYJbGB_A3dUcB38IV5OcZ0f3Ce-8F1tZylPpp9h6z2wM7B1VfyD79AVjR4etPVtHtiDJDf4x9jhMBl1A0pGgIkxG57JsEYc1JyGJTYubLvIf39liO3QJhLXrKO3wEZyfvv28POPzVQrcl0YNXLbKVcII5UQpnJBGBR-sar1K_KtNEGlZl1VwwWvvhUQsXXAoDTqnrNNl-RgOYhfxKbDUUFcY8sqhTg3RSmE1Op1jXbc6FBmI3bdt_KwzTtddfG2uFZIJjybh0Yx4NJcZvN63-TapbPzT-ngHWTOvuL4pdOKiuSlUmcHL_eO0VigAYiN2W7JJBCURoFpm8GSCej9cmZhqLU2dwZsd9ted__1dnv2f-XO4V4zzkFJ_juFg2GzxJLGawb0Yp_NPqWnxcA
  priority: 102
  providerName: Springer Nature
Title Clinicopathological Manifestations and Immune Phenotypes in Adult-Onset Immunodeficiency with Anti-interferon-γ Autoantibodies
URI https://link.springer.com/article/10.1007/s10875-022-01210-y
https://www.ncbi.nlm.nih.gov/pubmed/35089479
https://www.proquest.com/docview/2651907253
https://www.proquest.com/docview/2623890194
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bitQwGA7uLog34tnqOkTwToNNm0N7JXWYdVVmXcSB8arkVHZA0nXaudgrH8r38JnM32ZmkMW9aaFN2tAv-fvlPyL0Ki2V1NQwwp20hJnSEJ1yQ7gqhNJascbCRnF-Jk4X7NOSL6PCrYtulVuZOAhq2xrQkb_NROAaqcx4_u7yJ4GqUWBdjSU0DtARxIDC5quY7l08gnAeXBgzScOiZlkMmomhc4GpE_Blh6xmKbn698d0jW1es5QOP6CTe-huZI64GqG-j245_wDdnkfb-EP0a0zx2UKN4a1Ew3MFvivdaG_vsPIWf4SIEIfPL5xvQQHb4ZXHFaThIF985_qxQWsd5JaAwEwMulpc-X5FILnEunHr1pM_v3G16dsAzEq34Ir4CC1OZt-mpySWVyAml7wnrOG6oJJyTXOqKZPcGqt4Y3jgZE2ATbAyL6y2RhhDmXO5ttox6bTmSos8f4wOfevdU4RDR1E4mxbaidDRKUaVcFqkriwbYbME0e23rU3MPQ4lMH7U-6zJgEcd8KgHPOqrBL3e9bkcM2_c2Pp4C1kdV2FX7-dMgl7ubof1A0YR5V27gTaBtARSVLIEPRmh3r0uD-y1ZLJM0Jst9vuH_38sz24ey3N0JxvmHbj_HKPDfr1xLwKz6fUEHcilnAyTeIKOqg_fP8_C-f3s7PxruDoV03BcZNVfibb92Q
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqrQRcEG8CBYwEJ7DIw3aSQ4UWaLVLu0uFWqm34MdEVEJJ2WSF9sSP4s5P4DfhSZxdoYreeo7tWJ7xzHge3xDyIsxVqiPDmYDUMm5yw3QoDBMqk0prxUuLD8XZXE5O-MdTcbpFfg-1MJhWOcjETlDb2qCP_E0sna0RprFI3p5_Z9g1CqOrQwsN5Vsr2N0OYswXdhzA6od7wjW70w-O3i_jeH_v-P2E-S4DzCSpaBkvhc6iNBI6SiId8VRYY5UojXCmSel2L3meZFZbI42JOECirQaegtZCaYkOUacCtjk6UEZk-93e_OjzWhc49dAlUcZp5MQKj33Zji_ec28Fhtn0iKsWstW_qvGCvXshVtupwP1b5Ka3Xem4Z7bbZAuqO-TazEfn75KfPchojV2OB5lKZwqzZ5o-4t9QVVk6xZoUoEdfoarRBdzQs4qOEQiEfaoaaPsBtQVEt8DSUIreYjp2J88Q3mJRwqKu2J9fdLxsa8caZ7rGZMh75ORKjv4-GVV1BQ8JdRNlBjbMNEg3ERSPlAQtQ8jzUto4INFwtoXx6OfYhONbscFtRnoUjh5FR49iFZBX6znnPfbHpaN3BpIVXg40xYZrA_J8_dndYAzLqArqJY5xZpMzy3IekAc9qde_S5z9nPM0D8jrgfabxf-_l0eX7-UZuT45nh0Wh9P5wWNyI-54EJORdsioXSzhibOzWv3UMzMlX676_vwFrsg9Tg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqVqq4IN4EChgJTmA1D9tJDhVaaFddyi4rRKXegl8RlVBSNlmhPfGj-Bcc-E3MJM6uUEVvPcdOHM94ZjyPbwh5EeYq1ZHhTLjUMm5yw3QoDBMqk0prxUuLF8XpTB6f8vdn4myL_B5qYTCtcpCJnaC2tUEf-X4swdYI01gk-6VPi5gfjt9cfGfYQQojrUM7DeXbLNiDDm7MF3mcuNUPuM41B5NDoP3LOB4ffX53zHzHAWaSVLSMl0JnURoJHSWRjngqrLFKlEaAmVLCn0ieJ5nV1khjIu5coq12PHVaC6UlOkdBHeykoPXhIrjz9mg2_7TWC6AquoTKOI1AxPDYl_D4Qj64NzDMrEeMtZCt_lWTl2zfS3HbTh2Ob5Gb3o6lo57xbpMtV90hu1Mfqb9LfvaAozV2PB7kK50qzKRp-uh_Q1Vl6QTrUxydf3VVje7ghp5XdISgIOxj1bi2H1Bbh0gXWCZK0XNMR7DzDKEuFqVb1BX784uOlm0NbHKua0yMvEdOr2Xr75Ptqq7cQ0JhosycDTPtJEx0ikdKOi1Dl-eltHFAomFvC-OR0LEhx7dig-GM9CiAHkVHj2IVkFfrORc9DsiVo_cGkhVeJjTFhoMD8nz9GE4zhmhU5eoljgETCky0nAfkQU_q9ecSsKVznuYBeT3QfvPy_6_l0dVreUZ24RwVHyazk8fkRtyxIOYl7ZHtdrF0T8DkavVTz8uUfLnu4_MXey5Bkg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinicopathological+Manifestations+and+Immune+Phenotypes+in+Adult-Onset+Immunodeficiency+with+Anti-interferon-%CE%B3+Autoantibodies&rft.jtitle=Journal+of+clinical+immunology&rft.au=Yi-Chun%2C+Chen&rft.au=Shao-Wen%2C+Weng&rft.au=Ding+Jing-Ya&rft.au=Chen-Hsiang%2C+Lee&rft.date=2022-04-01&rft.pub=Springer+Nature+B.V&rft.issn=0271-9142&rft.eissn=1573-2592&rft.volume=42&rft.issue=3&rft.spage=672&rft.epage=683&rft_id=info:doi/10.1007%2Fs10875-022-01210-y&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-9142&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-9142&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-9142&client=summon